Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1457, 2004-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Selective COX-2 inhibitors may pose a greater risk of hyperkalaemia than nonselective NSAIDs
Reactions Weekly, Vol. 1, Iss. 1325, 2010-01 ,pp. :
COX-2 use grows despite little added benefit over NSAIDs
Reactions Weekly, Vol. 1, Iss. 1037, 2005-01 ,pp. :
COX-2 use grows despite little added benefit over NSAIDs
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 471, 2005-01 ,pp. :
COX-2 use grows despite little added benefit over NSAIDs
Inpharma, Vol. 1, Iss. 1474, 2005-01 ,pp. :